Literature DB >> 21691942

Elevated gray and white matter densities in cocaine abstainers compared to current users.

Colleen A Hanlon1, Darin L Dufault, Michael J Wesley, Linda J Porrino.   

Abstract

RATIONALE: Numerous neuroimaging studies have demonstrated lower neural tissue density in chronic cocaine users, which may be linked to cognitive dysfunction.
OBJECTIVES: The goal of this study was to determine whether neural tissue density was also impaired in individuals abstinent from cocaine and whether any observed changes were associated with cognitive performance.
METHODS: A total of 73 participants were included: 24 active cocaine users, 24 abstainers (abstinent for at least 1 month), and 25 nondrug-abusing controls rigorously matched for age, gender, and IQ. All participants performed a cognitive assessment battery and received an MRI which was analyzed using voxel-based morphometry.
RESULTS: The abstainers had significantly higher gray matter density than the current cocaine users in neocortical areas including the frontal and temporal cortex. In contrast to the users, there was no difference in white matter density in the abstainers relative to the controls. The abstainers performed better than current users on several behavioral tasks. Within users and abstainers, cortical density was correlated with performance on memory and reaction time tasks. Subcortical gray matter density was lower in both the users and abstainers relative to the controls. Within abstainers, subcortical tissue density was correlated with the ability to set-shift.
CONCLUSIONS: These data suggest that individuals able to remain abstinent from cocaine for at least 1 month have elevated neocortical tissue density and perform better on multiple cognitive tests, relative to current cocaine users. Larger, longitudinal studies are needed to address this interaction between abstinence, cognition, and cortical tissue density directly.

Entities:  

Mesh:

Year:  2011        PMID: 21691942      PMCID: PMC3197798          DOI: 10.1007/s00213-011-2360-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  38 in total

1.  Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers.

Authors:  A Bechara; S Dolan; N Denburg; A Hindes; S W Anderson; P E Nathan
Journal:  Neuropsychologia       Date:  2001       Impact factor: 3.139

2.  Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study.

Authors:  Kelvin O Lim; Steven J Choi; Nunzio Pomara; Adam Wolkin; John P Rotrosen
Journal:  Biol Psychiatry       Date:  2002-06-01       Impact factor: 13.382

3.  Chronic drug use and cognitive impairments.

Authors:  Robert I Block; Wesley J Erwin; M M Ghoneim
Journal:  Pharmacol Biochem Behav       Date:  2002-10       Impact factor: 3.533

4.  Distinct brain systems underlie the processing of valence and arousal of affective pictures.

Authors:  M M A Nielen; D J Heslenfeld; K Heinen; J W Van Strien; M P Witter; C Jonker; D J Veltman
Journal:  Brain Cogn       Date:  2009-08-08       Impact factor: 2.310

5.  Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M Sedler; S J Gatley; E Miller; R Hitzemann; Y S Ding; J Logan
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

6.  Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients.

Authors:  Teresa R Franklin; Paul D Acton; Joseph A Maldjian; Jason D Gray; Jason R Croft; Charles A Dackis; Charles P O'Brien; Anna Rose Childress
Journal:  Biol Psychiatry       Date:  2002-01-15       Impact factor: 13.382

Review 7.  Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex.

Authors:  N D Volkow; J S Fowler
Journal:  Cereb Cortex       Date:  2000-03       Impact factor: 5.357

8.  Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence.

Authors:  Victoria Di Sclafani; Marina Tolou-Shams; Leonard J Price; George Fein
Journal:  Drug Alcohol Depend       Date:  2002-04-01       Impact factor: 4.492

9.  Prefrontal cortical volume reduction associated with frontal cortex function deficit in 6-week abstinent crack-cocaine dependent men.

Authors:  George Fein; Victoria Di Sclafani; Dieter J Meyerhoff
Journal:  Drug Alcohol Depend       Date:  2002-09-01       Impact factor: 4.492

10.  Cocaine-primed craving and its relationship to depressive symptomatology in individuals with cocaine dependence.

Authors:  Igor Elman; Katherine H Karlsgodt; David R Gastfriend; Christopher F Chabris; Hans C Breiter
Journal:  J Psychopharmacol       Date:  2002-06       Impact factor: 4.153

View more
  44 in total

Review 1.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

2.  Functional consequences of cocaine re-exposure after discontinuation of cocaine availability.

Authors:  Thomas J R Beveridge; Hilary R Smith; Susan H Nader; Michael A Nader; Linda J Porrino
Journal:  Neuropharmacology       Date:  2014-06-19       Impact factor: 5.250

3.  Persistent cocaine-induced reversal learning deficits are associated with altered limbic cortico-striatal local field potential synchronization.

Authors:  Clinton B McCracken; Anthony A Grace
Journal:  J Neurosci       Date:  2013-10-30       Impact factor: 6.167

4.  Regional elevations in microglial activation and cerebral glucose utilization in frontal white matter tracts of rhesus monkeys following prolonged cocaine self-administration.

Authors:  Hilary R Smith; Thomas J R Beveridge; Susan H Nader; Michael A Nader; Linda J Porrino
Journal:  Brain Struct Funct       Date:  2019-02-12       Impact factor: 3.270

5.  Structural brain differences in alcohol-dependent individuals with and without comorbid substance dependence.

Authors:  Anderson Mon; Timothy C Durazzo; Christoph Abe; Stefan Gazdzinski; David Pennington; Thomas Schmidt; Dieter J Meyerhoff
Journal:  Drug Alcohol Depend       Date:  2014-09-19       Impact factor: 4.492

6.  PPAR-gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: a double-blind randomized controlled pilot trial.

Authors:  Joy M Schmitz; Charles E Green; Khader M Hasan; Jessica Vincent; Robert Suchting; Michael F Weaver; F Gerard Moeller; Ponnada A Narayana; Kathryn A Cunningham; Kelly T Dineley; Scott D Lane
Journal:  Addiction       Date:  2017-07-03       Impact factor: 6.526

7.  Cocaine-induced loss of white matter proteins in the adult mouse nucleus accumbens is attenuated by administration of a β-lactam antibiotic during cocaine withdrawal.

Authors:  Jane Kovalevich; Gladys Corley; William Yen; Scott M Rawls; Dianne Langford
Journal:  Am J Pathol       Date:  2012-09-29       Impact factor: 4.307

8.  Regionally-specific alterations in myelin proteins in nonhuman primate white matter following prolonged cocaine self-administration.

Authors:  Hilary R Smith; Thomas J R Beveridge; Michael A Nader; Linda J Porrino
Journal:  Drug Alcohol Depend       Date:  2014-01-30       Impact factor: 4.492

9.  Cerebral gray matter volumes and low-frequency fluctuation of BOLD signals in cocaine dependence: duration of use and gender difference.

Authors:  Jaime S Ide; Sheng Zhang; Sien Hu; Rajita Sinha; Carolyn M Mazure; Chiang-Shan R Li
Journal:  Drug Alcohol Depend       Date:  2013-09-17       Impact factor: 4.492

10.  Performance on a strategy set shifting task in rats following adult or adolescent cocaine exposure.

Authors:  Kathleen M Kantak; Nicole Barlow; David H Tassin; Madeline F Brisotti; Chloe J Jordan
Journal:  Psychopharmacology (Berl)       Date:  2014-05-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.